Skip to main content

Table 1 Baseline characteristics of COVID-19 patients

From: Clinical course and outcome of 107 patients infected with the novel coronavirus, SARS-CoV-2, discharged from two hospitals in Wuhan, China

Characteristics

Total (n = 107)

Survivors (n = 88)

Non-survivors (n = 19)

P value

Age, years

51.0 (36.0–65.0)

44.5 (35.0–58.8)

73.0 (64.0–81.0)

< 0.001*

 < 45

46 (43.0)

44 (50.0)

2 (10.5)

0.002

 45–59

25 (23.4)

24 (27.3)

1 (5.3)

0.041

 60–75

23 (21.5)

16 (18.2)

7 (36.8)

0.119

 > 75

13 (12.1)

4 (4.5)

9 (47.4)

< 0.001

Sex

   

0.003*

 Male

57 (53.3)

41 (46.6)

16 (84.2)

 

 Female

50 (46.7)

47 (53.4)

3 (15.8)

 

Comorbidity

 Any comorbidity*

41 (38.3)

28 (31.8)

13 (68.4)

0.003

 Hypertension

26 (24.3)

16 (18.2)

10 (52.6)

0.001*

 Cardiovascular disease

13 (12.1)

6 (6.8)

7 (36.8)

0.002*

 Diabetes

11 (10.3)

6 (6.8)

5 (26.3)

0.024*

 Chronic liver disease

6 (5.6)

5 (5.7)

1 (5.3)

1.000

 Cerebrovascular disease

6 (5.6)

3 (3.4)

3 (15.8)

0.068

 COPD

3 (2.8)

2 (2.3)

1 (5.3)

0.447

 Chronic kidney disease

3 (2.8)

2 (2.3)

1 (5.3)

0.447

Symptoms and signs

 Fever

104 (97.2)

85 (96.6)

19 (100.0)

1.000

 Dry cough

67 (62.6)

56 (63.6)

11 (57.9)

0.639

 Fatigue

69 (64.5)

55 (62.5)

14 (73.7)

0.356

 Dyspnea

35 (32.7)

20 (22.7)

15 (78.9)

< 0.001*

 Anorexia

33 (30.8)

25 (28.4)

8 (42.1)

0.241

 Myalgia

33 (30.8)

28 (31.8)

5 (26.3)

0.638

 Pharyngalgia

12 (11.2)

11 (12.5)

1 (5.3)

0.689

 Headache

7 (6.5)

7 (8.0)

0 (0)

0.348

 Dizziness

7 (6.5)

7 (8.0)

0 (0)

0.348

 Diarrhea

7 (6.5)

3 (3.4)

4 (21.1)

0.018*

 Nausea

6 (5.6)

6 (6.8)

0 (0)

0.588

 Vomiting

3 (2.8)

2 (2.3)

1 (5.3)

0.447

 Abdominal pain

2 (1.9)

1 (1.1)

1 (5.3)

0.325

Heart rate (bpm)

86 (75–96)

85 (75–96)

90 (78–100)

0.240

Respiratory rate

20 (19–21)

20 (19–21)

22 (20–24)

0.003*

Mean arterial pressure (mmHg)

89 (83–98)

88 (83–96)

95 (89–101)

0.019*

Onset of symptom to admission (days)

7.0 (3.5–9.0)

7.0 (3.0–9.8)

6.0 (4.0–7.0)

0.405

Onset of symptom to dyspnea (days)

5.5 (2.0–9.3)

7.0 (3.3–10.8)

4.0 (1.8–7.5)

0.103

Onset of symptom to ARDS (days)

7.5 (4.3–11.0)

10.0 (6.0–13.0)

7.0 (3.5–9.0)

0.081

Length of hospital stay (days)

11.0 (7.0–15.0)

10.5 (7.0–14.0)

14.0 (6.0–17.0)

0.561

  1. Data are median (IQR), n (%). P values indicate differences between survivors and non-survivors. P < 0.05 was considered significant. Vital signs including heart rate, respiratory rate, and mean arterial pressure were collected at admission
  2. COPD chronic obstructive pulmonary disease, ARDS acute respiratory distress syndrome, bpm beats per minute
  3. *One patient had the comorbidity of lung cancer and died of ARDS
Back to article page

Critical Care

ISSN: 1364-8535